Healthcare -
Biotechnology - NASDAQ - BM
$ 29.76
2.22 %
$ 2.17 B
Market Cap
-118.08
P/E
KNSA - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities KNSA - Kiniksa Pharmaceuticals, Ltd.
12.3 M
LAST VALUE
120.80%
2 YEAR CAGR
-31.96%
5 YEAR CAGR
0.00%
10 YEAR CAGR